- Home
- / Applied Genetic Technologies
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Applied Genetic Technologies financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0.4
2022-12-09
Market Capitalization
$16.9 M
2022-12-09
Revenue
$325 K
FY, 2022
CreditSafe Score
?
Score changed on Jun 06, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.1M | 2.4M | 47.4M | 39.5M | 24.2M | 41.7M | 2.5M | 500.0K | 325.0K |
| Revenue growth, % | 108.5% | 1911.9% | |||||||
| General and administrative expense | 5.2M | 10.4M | 10.6M | 11.4M | 14.4M | 13.6M | 14.6M | 17.0M | |
| Operating expense total | 13.7M | 26.9M | 49.5M | 37.6M | 46.6M | 33.2M | 49.4M | 66.5M | |
| EBIT | (12.6M) | (24.5M) | (2.1M) | 1.9M | (22.4M) | (4.3M) | (46.9M) | (58.5M) | (66.2M) |
| EBIT margin, % | -1112.1% | -1042.1% | -4.4% | 4.8% | -92.5% | -10.4% | -1913.7% | -20361.5% | |
| Investment income | 216.0K | 711.0K | 952.0K | 1.3M | 2.0M | 1.2M | 116.0K | 99.0K | |
| Interest income | 42.0K | ||||||||
| Interest expense | 3.4M | 214.0K | 708.0K | 905.0K | 1.2M | 2.5M | 2.7M | ||
| Pre tax profit | 2.8M | (21.2M) | (1.9M) | (45.8M) | (59.8M) | (68.7M) | |||
| Income tax expense | 2.4M | 72.0K | 76.0K | 83.0K | (2.1M) | ||||
| Net Income | (15.9M) | (24.3M) | (1.4M) | 407.0K | (21.3M) | (2.0M) | (45.9M) | (57.8M) | (68.9M) |